Skip to main content

Nonprofit · EIN 33-1267965

BLUE NEVUS MELANOMA FOUNDATION

Tax-exempt · ATHERTON, CA 94027

Financials

$123K$42K2025
Revenue Expenses · by fiscal year end
Financials of BLUE NEVUS MELANOMA FOUNDATION by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2025990-EZ (amended)$122,589$41,779$80,810$82,990$0$82,990
Financial details: 990-EZ for the year ended December 31, 2025

Revenue

Contributions, gifts and grants
$123,186
Program service revenue
$0
Investment income
$0
Net income from fundraising events
-$6,597
Other revenue
$6,000

Expenses

Grants and similar amounts paid
$41,779
Compensation of officers, directors and key employees
$0
Salaries, compensation and benefits (total)
$0
Program services (functional)
$6,597

Balance sheet and other

Total assets, start of year
$2,180
Total assets, end of year
$82,990
Total liabilities, end of year
$0
Net assets, end of year
$82,990
Cash, savings and investments
$82,990
Gross receipts
$129,186

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990-EZ for the year ended December 31, 2025, highest compensation first.

NameTitleHours / weekCompensation
Maya SkubatchSecretery1$0
Ariela TannenbaumCFO0.1$0
Vern NorvielCEO0.1$0

Address and contacts

Address (IRS master file)
52 MONTE VISTA AVE, ATHERTON, CA 94027-5431
Signed the 990-EZ
Maya Skubatch, Director
Phone
(650) 799-8593

California records

California keeps its own records of charities and corporations. Search them by EIN 33-1267965 or by the name BLUE NEVUS MELANOMA FOUNDATION.

Attorney General, Registry of Charities and Fundraisers
Registration status and filed reports (CT-TR-1, RRF-1)

Mission

A foundation to support research for Blue Nevus Melanoma (BNM). BNM is an ultra rare condition and an aggressive form of Melanoma cancer. There is a dire need to develop new treatments and drugs for it as the standard of care for Melanoma is not effective against Blue Nevus Melanoma.

990-EZ for the year ended December 31, 2025

Program accomplishments

  • In 2025, the foundation initiated a research to develop a new drug for Blue Nevus Melanoma (BNM). the foundation supported a UCSF lab to extend their work to also study BNM. In 2025, the foundations grants Research so far supported UCSF lab to collaborate with an external company to screen a large library of 1.2 trillion molecules. The screening identified a handful of candidates that are now being evaluated for further studies as candidate for an initial future medication.
    Expenses $4,597 · grants $26,500
  • Supported a research to develop Organiods with the Rare Cancer Research Foundation. Organoids allows for faster drug development as they provide a way to simulate new drugs impact in a lab settings. This research attempt was not successful.
    Expenses $2,000 · grants $15,279

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026990-EZ on file
2024December 31, 2024May 15, 2025Check at the IRS
2023December 31, 2023May 15, 2024Check at the IRS

IRS record

EIN
33-1267965
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
2024
Accounting year ends
December
Files
Form 990 or 990-EZ
Assets (IRS master file)
$82,990
Income (IRS master file)
$129,186

Filing history

FormYear endedRevenueExpensesAssetsReturn
990-EZDecember 2025$122,589$41,779$82,990IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 33-1267965).

Questions about BLUE NEVUS MELANOMA FOUNDATION

What is the EIN of BLUE NEVUS MELANOMA FOUNDATION?
The employer identification number (EIN) of BLUE NEVUS MELANOMA FOUNDATION is 33-1267965.
Is BLUE NEVUS MELANOMA FOUNDATION tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2024.
Are donations to BLUE NEVUS MELANOMA FOUNDATION tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does BLUE NEVUS MELANOMA FOUNDATION file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of BLUE NEVUS MELANOMA FOUNDATION due?
The return for tax year 2026 (the year ending December 31, 2026) is due May 17, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
When did BLUE NEVUS MELANOMA FOUNDATION last file with the IRS?
The latest return in the IRS public files is the 990-EZ for the year ended December 2025.
Who are the officers and directors of BLUE NEVUS MELANOMA FOUNDATION?
The 990-EZ for the year ended December 31, 2025 lists 3 people; 0 received compensation from the organization.
How much revenue does BLUE NEVUS MELANOMA FOUNDATION have?
On its 990-EZ for the year ended December 31, 2025 it reported revenue of $122,589, expenses of $41,779 and total assets of $82,990 at year end.

Other nonprofits in ATHERTON

All nonprofits in ATHERTON · California · Voluntary health associations and medical disciplines